FIEE Q1 2023 Earnings Significant EPS Miss Drags Stock Lower WYY Q1 2026 Earnings Strong EPS Surprise Drives DoubleDigit Stock Rally Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount RDI Q3 2025 Earnings EPS Misses Estimates Amid Operational Challenges NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances HURN Q1 2026 Earnings Earnings Per Share Surpasses Consensus by 58